GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract HHSN268201400006CVASCULAR BIOSCIENCES

Overview

Award facts

Net obligations
$1.15M
$1,149,127of $1.15M potential value
Period of performance
Nov 15, 2013 to Nov 14, 2016
Ended
Modifications
4
Latest action Apr 13, 2020
Contract type
Definitive contract
PIID HHSN268201400006C

Description of requirement

IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): CAR PEPTIDE THERAPEUTIC ADJUVANT FOR PAH TARGETED THERAPY

Dates and value

Award date
Signed on Nov 15, 2013
Potential end of performance
Nov 13, 2016
Current value
$1,149,127Base and exercised options
Potential value (if all options are exercised)
$1,149,127

Obligations by fiscal year of action

  • FY2016: $385,534
  • FY2015: $401,635
  • FY2014: $361,958

Total across 3 fiscal years: $1,149,127

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Apr 13, 2020. View on USAspending · Recipient on SAM.gov

Recipient

LocationDURHAM, NC
UEIETJLM26WRKP5
CAGE code3YCF8
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyVASCULAR BIOSCIENCES

Business types and certifications

Self-certified small disadvantaged businessLabor surplus area firm (Department of Labor)For-profit organizationCorporation (not tax-exempt)Manufacturer of goods

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NHLBI
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NHLBI

Place of performance

Place of performance
Durham, North Carolina 27703-5420
Congressional district (place of performance)
NC-04As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
31

Contract details

Subcontracting plan
Plan not requiredB
Major program
Igf::ot::igf vascular interventions/innovations and therapeutic advances (VITA): car peptide therape
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
Yes
Commercial procedures
Commercial item procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not a bundled requirementD
Consolidated requirement
No
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Nov 15, 2013Base obligation at award: $361,958
Latest action
Apr 13, 2020 — CloseoutModification P00004; administrative: no change in scope or value
Latest substantive action
Nov 13, 2015 — Option exercisedModification 3; obligation change +$385,534
Actions by type
  • Base award1
  • Option exercised2
  • Closeout1
  • Other administrative action1
5 actions recorded, Nov 15, 2013 to Apr 13, 2020; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Closely associatedCL
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N920
Transactions recorded under this award key
5

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N920